SEC Form 5 · accession 0001185185-17-001512
INVO Bioscience, Inc. · IVOB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kathleen t Karloff
Officer — CEO/Chairman · Director
Period of report
Dec 31, 2013
Accepted (ET)
Jul 3, 2017 · 3:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001417926
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| INVO Bioscience Common Stock (Restricted) | Feb 5, 2013 | A | 4,000,000 | $0.005 | A | 10,960,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
Purely an oversight, did not realize the grant had to be reported along with other transactions. In the process of catching up on all past transactions that were missed.